KRBPQ — Kiromic Biopharma Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Kiromic Biopharma rises on plans to begin trial for cancer cell therapy
Brief: Kiromic Biopharma Announces Company Will Directly Submit Amended Ind For Procel To The FDA In Second Half Of 2022
Brief: Kiromic Biopharma Inc - On May 10, 2022, Board Of Kiromic Biopharma, Inc. Appointed Pietro Bersani To Role Of Chief Executive Officer
Kiromic Biopharma Inc reports results for the quarter ended in September - Earnings Summary
Brief: Kiromic Biopharma Inc Says Cash And Cash Equivalents Were $36,161,800 As Of September 30, 2021
U.S. STOCKS ON THE MOVE-Bed Bath & Beyond, Coinbase, Citigroup
Brief: Kiromic Biopharma Says Pietro Bersani Has Been Appointed Interim CEO
U.S. STOCKS ON THE MOVE-Remark Holdings, Erytech Pharma, Pinterest, Bakkt Holdings
U.S. STOCKS ON THE MOVE-Pinterest, Tesla, Erytech Pharma, Remark
U.S. STOCKS ON THE MOVE-Remark Holdings, PAE, Tesla, Xeris
Kiromic BioPharma soars as cancer vaccine shows promise
Brief: Kiromic Reports Significant Progression Free Survival Benefit In Metastatic Pancreatic Cancer Patient Treated With KiroVax/BSK01
Brief: Kiromic Biopharma Inc Announces Strategic Collaboration With Gemelli Teaching Hospital
Brief: Kiromic Biopharma Says Daniel Clark Appointed As Interim Chief Financial Officer
Brief: Kiromic Biopharma - On September 29, 2021, Tony Tontat, CFO Of Co Notified Co Of His Decision To Resign From His Positions At Co Effective Immediately
Brief: Kiromic Biopharma Acquires Insilico Solutions
NASDAQ RESUMED AT 02:58 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:56 PM
Brief: Kiromic Biopharma Provides Update On IND Filings On Its Off-The-Shelf, Allogeneic Car-T For Solid Tumors